Lixte Biotech Holdings (LIXT) Competitor Comparison
We are evaluating the key criteria listed to compare Lixte Biotech Holdings (LIXT) against its competitors in the Biotechnology industry.
Market Capitalization
356 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
0 / 337Free Cashflow
52 / 352Quick Ratio
39 / 357Earnings per Share
194 / 359Dividend yield
0 / 6Total Cash
337 / 358Performance 3 years
302 / 368Performance 5 years
250 / 368Performance 10 years
109 / 368Linearity 3 years
237 / 368Linearity 5 years
106 / 368Linearity 10 years
11 / 368Total Rank
184 / 368Dividend Rank
191 / 368Valuation Rank
141 / 368Piotroski Rank
82 / 368Muliplier Rank
144 / 368Linearity 3 years - LIXT ranking 237 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.